CIAM
MRVI icon

Caitong International Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Caitong International Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37K Sell
485
-4,234
-90% -$14.4K ﹤0.01% 1336
2025
Q4 		$15.3K Buy
+4,719
New +$15.9K ﹤0.01% 1051

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caitong International Asset Management's MRVI Position: Q1 2026 in Review

Caitong International Asset Management reduced its Maravai LifeSciences (MRVI) stake by 90% in Q1 2026, selling an estimated $14.4K and leaving 485 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Caitong International Asset Management first reported a position in MRVI in Q4 2025 and has held it in 2 quarters since. The position peaked at $15.3K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Caitong International Asset Management held 485 shares of Maravai LifeSciences worth $1.37K as of Q1 2026.
  • Caitong International Asset Management sold 4,234 Maravai LifeSciences shares in Q1 2026, an estimated $14.4K.
  • Maravai LifeSciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1336 holding.
  • Caitong International Asset Management first reported a position in Maravai LifeSciences in Q4 2025 and has held it in 2 quarters since.
  • Caitong International Asset Management's Maravai LifeSciences position peaked at $15.3K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.